LATAM OTC Results Round-Up: Mexico's Genomma Lab, Brazil's Hypera

Genomma enjoys broad-based growth in 2018, while NPD investments pay off for Hypera.

Coins
• Source: Shutterstock

Mexico’s Genomma Lab Internacional SAB de CVreported OTC sales up by 14.2% to MXN6.07bn ($314m) in 2018, as turnover improved at a double-digit rate in all three of its reporting regions.

More from Earnings

More from Business